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Recent research suggests that marijuana use may be posi-
tively associated with risk of human papillomavirus
(HPV)-associated oropharyngeal cancer, and the immu-
nomodulatory effects of cannabinoids are considered a
possible mechanism. Were marijuana to have systemic
effects on HPV-associated tumorigenesis it would be of
major concern, and might be especially harmful in immu-
nologically susceptible populations such as HIV-positive
women.
We studied the effect of marijuana use on cervical HPV
natural history and cervical squamous intraepithelial
lesions (SIL) among HIV-positive and HIV-negative
women in the Women's Interagency HIV Study (WIHS), a
large prospective cohort study. HPV DNA testing by PCR
and Pap smears were conducted semi-annually. Prevalent
HPV and cervical SIL were analyzed using logistic regres-
sion with GEE. Persistence of HPV was analyzed using Cox
regression.
Of the 3,499 women in the WIHS, 1,414 reported ever
using marijuana. There were no associations between
HPV prevalence and either current (OR = 0.98 95% CI =
0.90–1.07), frequent (current daily use: OR = 0.98 95 CI
= 0.90–1.07), or sustained (daily use for more than 3
years: OR = 1.03, 95% CI = 0.90–1.19) marijuana use,
controlling for age, race, HIV status, CD4 cell count,
number of sexual partners in the last 6 months, tobacco
use and cervical treatment. Nor were there effects on prev-
alence of SIL, or on the persistence of cervical HPV infec-
tion. Results were similar among HIV-negative and HIV-
positive women.
Our data do not support an effect of marijuana on cervical
HPV infection, persistence or risk of cervical dysplasia. If
there is an effect of marijuana use on oral HPV-associated
tumorigenesis, it may be a local effect.
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